Category Archives: Depakote

Featured Stories

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Study: Epilepsy Drug, Valproate, Linked to Increased Autism Risks

Use of anticonvulsant drug valproate by expectant mothers has been linked to an increased autism risk in their babies, a new study reveals. Valproate is used in the treatment of epilepsy, said the Global Times; however, its use by pregnant … Continue reading

Posted in Depakote, Legal News, Pharmaceuticals |

Abbot Hit With Massive Off-Label Fines

Abbott Laboratories was just hit with a massive fine for off-label practices, the second-largest such criminal fine for a single medication. A federal district judge in Virginia ordered Abbott Laboratories to pay a $500 million criminal fine and a forfeiture … Continue reading

Posted in Depakote, Legal News, Pharmaceuticals |

Lawsuits Claim Abbott Illegally Marketed Depakote

A total of 26 women have recently filed lawsuits claiming the makers of the anti-seizure drug Depakote illegally marketed the drug for off-label purposes and failed to warn of the side effects of the drug. Each of the women, according … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged |

Abbott Pleads Guilty In Depakote Marketing Case, Agrees to Pay $1.5 Billion to Resolve Justice Department Charges

It was announced yesterday that Abbott Laboratories has pleaded guilty in a Depakote marketing case. According to the U.S. Department of Justice, Abbott promoted the drug for nonapproved uses. Depakote (divalproex sodium) is an anti-seizure medication approved to treat epilepsy, … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged |

Depakote Legal Troubles Not Over for Abbott

Depakote continues to pose more legal challenges for Abbott Laboratories (ABT). Among other issues, the company has allegedly violated consumer protection laws in relation to Depakote’s sale and marketing. After allegations of off-market labeling and U.S. Justice Department investigation last … Continue reading

Posted in Depakote, Pharmaceuticals |

Depakote During Pregnancy Linked to Autism Spectrum Disorder

A new study has found more evidence that Depakote may be dangerous to a developing fetus. The study, conducted by Danish researchers, concluded that children who are exposed to valproate, the active ingredient in Depakote, face nearly three times the … Continue reading

Posted in Depakote, Pharmaceuticals |

Pending Depakote Settlement Sparks Abbott Shareholder Lawsuit

Shareholders of Abbott Laboratories have filed a lawsuit stemming from the drug maker’s pending settlement with the federal government over charges it illegally marketed the anti-seizure medication, Depakote (valproic acid), for off-label uses. The lawsuit, which was filed in Illinois … Continue reading

Posted in Depakote, Pharmaceuticals |

Depakote in Pregnancy May Cause Cognitive Impairment

The U.S. Food and Drug Administration (FDA) has warned the public that children born to women who take the anti-seizure medication < "http://www.yourlawyer.com/topics/overview/depakote">Depakote (valproate sodium) or related products (valproic acid and divalproex sodium), when pregnant, may give birth to babies … Continue reading

Posted in Depakote, Pharmaceuticals |

Fetal Exposure to Depakote, Similar Epilepsy Drugs May Impair Cognitive Development

Valproate medications, including < "http://www.yourlawyer.com/topics/overview/Depakote-Lawsuit-Lawyer-Birth-Defects">Depakote, Depakon, Depakene and Stavzor, may negatively impact a child’s IQ if they are taken during pregnancy. The U.S. Food & Drug Administration (FDA) announced yesterday that it will be revising the labels of all valproate … Continue reading

Posted in Depakote, Pharmaceuticals |

Epilepsy Drugs May Up Risk of Pregnancy Complications

Recently, we’ve done quite a bit of reporting on the link between epilepsy drugs like < "http://www.yourlawyer.com/topics/overview/Depakote-Lawsuit-Lawyer-Birth-Defects">Depakote and birth defects. Now a new study finds that such drugs might also increase the risk that pregnant women who take them will … Continue reading

Posted in Depakote, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.